NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free COCH Stock Alerts $5.18 +0.12 (+2.37%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$4.97▼$5.4250-Day Range$1.21▼$9.9552-Week Range$0.75▼$11.72Volume59,498 shsAverage Volume352,096 shsMarket Capitalization$101.53 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Envoy Medical alerts: Email Address Envoy Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside15.8% Upside$6.00 Price TargetShort InterestHealthy0.50% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.80) to ($0.78) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.47 out of 5 starsMedical Sector691st out of 913 stocksSurgical Appliances & Supplies Industry15th out of 18 stocks 2.5 Analyst's Opinion Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.50% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envoy Medical has recently decreased by 28.24%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for COCH. Previous Next 2.5 News and Social Media Coverage News SentimentEnvoy Medical has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Envoy Medical this week, compared to 2 articles on an average week.Search InterestOnly 5 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.67% of the stock of Envoy Medical is held by insiders.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Envoy Medical are expected to grow in the coming year, from ($0.80) to ($0.78) per share. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Envoy Medical Stock (NASDAQ:COCH)Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Read More COCH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COCH Stock News HeadlinesApril 24, 2024 | finance.yahoo.comEnvoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024April 23, 2024 | americanbankingnews.comInogen (NASDAQ:INGN) vs. Envoy Medical (NASDAQ:COCH) Head-To-Head ContrastApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 21, 2024 | finance.yahoo.comEnvoy Medical, Inc. (COCH)April 20, 2024 | prnewswire.comROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 17, 2024 | msn.comEnvoy Medical (COCH) Price Target Increased by 25.00% to 5.10April 17, 2024 | markets.businessinsider.comROSEN, LEADING TRIAL ATTORNEYS, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 15, 2024 | prnewswire.comCOCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 5, 2024 | markets.businessinsider.comROSEN, A LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 3, 2024 | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 3, 2024 | finance.yahoo.comEnvoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024April 3, 2024 | globenewswire.comEnvoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024April 3, 2024 | markets.businessinsider.comCOCH Stock Earnings: Envoy Medical Beats EPS, Beats Revenue for Q4 2023April 2, 2024 | globenewswire.comEnvoy Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 29, 2024 | stockhouse.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 26, 2024 | markets.businessinsider.comROSEN, LEADING INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 24, 2024 | prnewswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 20, 2024 | markets.businessinsider.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 17, 2024 | prnewswire.comCOCH INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 12, 2024 | globenewswire.comEnvoy Medical to Participate in the 36th Annual ROTH ConferenceMarch 10, 2024 | markets.businessinsider.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 9, 2024 | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 7, 2024 | markets.businessinsider.comROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 4, 2024 | globenewswire.comEnvoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical TrialMarch 3, 2024 | finance.yahoo.comInsiders with their considerable ownership were the key benefactors as Envoy Medical, Inc. (NASDAQ:COCH) touches US$122m market capMarch 2, 2024 | prnewswire.comCOCH LOSS ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHSee More Headlines Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Next Earnings (Estimated)7/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:COCH CUSIPN/A CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+15.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,910,000.00 Net MarginsN/A Pretax Margin-9,464.56% Return on EquityN/A Return on Assets-100.39% Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio0.82 Sales & Book Value Annual Sales$320,000.00 Price / Sales317.28 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-57.56Miscellaneous Outstanding Shares19,600,000Free Float19,469,000Market Cap$101.53 million OptionableNot Optionable Beta2.68 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Brent T. Lucas Esq. (Age 41)CEO & Director Comp: $303.66kMr. David R. Wells (Age 62)Chief Financial Officer Comp: $283.77kKey CompetitorsCollPlant BiotechnologiesNASDAQ:CLGNVicarious SurgicalNYSE:RBOTMilestone ScientificNYSE:MLSSReWalk RoboticsNASDAQ:LFWDInogenNASDAQ:INGNView All CompetitorsInsiders & InstitutionsWeiss Asset Management LPBought 20,000 shares on 2/12/2024Ownership: 0.102%Brent T LucasBought 12,380 shares on 11/21/2023Total: $12,008.60 ($0.97/share)View All Insider TransactionsView All Institutional Transactions COCH Stock Analysis - Frequently Asked Questions Should I buy or sell Envoy Medical stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Envoy Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" COCH shares. View COCH analyst ratings or view top-rated stocks. What is Envoy Medical's stock price target for 2024? 2 Wall Street analysts have issued 1-year price objectives for Envoy Medical's shares. Their COCH share price targets range from $6.00 to $6.00. On average, they anticipate the company's share price to reach $6.00 in the next year. This suggests a possible upside of 15.8% from the stock's current price. View analysts price targets for COCH or view top-rated stocks among Wall Street analysts. How have COCH shares performed in 2024? Envoy Medical's stock was trading at $1.8106 at the start of the year. Since then, COCH shares have increased by 186.1% and is now trading at $5.18. View the best growth stocks for 2024 here. Are investors shorting Envoy Medical? Envoy Medical saw a decrease in short interest in April. As of April 15th, there was short interest totaling 30,500 shares, a decrease of 28.2% from the March 31st total of 42,500 shares. Based on an average daily volume of 425,900 shares, the short-interest ratio is currently 0.1 days. Currently, 0.5% of the company's stock are short sold. View Envoy Medical's Short Interest. When is Envoy Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024. View our COCH earnings forecast. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:COCH) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
